NCT06093724 Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)
| NCT ID | NCT06093724 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Limoges |
| Condition | Transgenderism |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-09-08 |
| Primary Completion | 2025-09-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-09-08 with a primary completion date of 2025-09-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.
Eligibility Criteria
Inclusion Criteria: * Patient over 18 years old * Patient admitted in urology ward at Limoges' University Hospital for MtF sexual reassignment surgery by vaginoplasty * Patient affiliated or benefitting from a social security system * Patient free, informed, written and signed consent Exclusion Criteria: * Patient admitted for vulvoplasty surgery * Patient admitted for second vaginoplasty surgical gesture * Contraindication of realizing an MRI
Frequently Asked Questions
Who can join the NCT06093724 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Transgenderism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06093724 currently recruiting?
Yes, NCT06093724 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Limoges to inquire about joining.
Where is the NCT06093724 trial being conducted?
This trial is being conducted at Limoges, France.
Who is sponsoring the NCT06093724 clinical trial?
NCT06093724 is sponsored by University Hospital, Limoges. The trial plans to enroll 50 participants.